CHRISTOPHER PARMANAND: Open Payments
NPI 1629578885 · ACTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 6 payments from 4 companies in 2025. Trend: 2023 $68 · 2024 $167 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
Products named: INVEGA SUSTENNA, UZEDY, CAPLYTA, Relexxii.
Industry payments across MA — which companies pay providers there.
